Exchange: NASDAQ·Updated 10:20 AM EDT
ACRV logo

ACRV ACRIVON THERAPEUTICS INC

$2.03
$0.03
(1.46%)
Today
Reported EarningsAug 12
Mkt Cap$88.28M
Vol27,412.00

About ACRV

Acrivon Therapeutics, Inc. develops drugs for clinical treatment. Its unique precision medicine platform is Acrivon Predictive Precision Proteomics (AP3). AP3 is used to generate proprietary OncoSignature companion diagnostics to identify patients who will benefit from the medicine. The company was founded by Peter Blume-Jensen and Kristina Masson in 2018 and is headquartered in Watertown, MA.
40

Bearish Sentiment

How do you feel about ACRV?

Advertisement|Remove ads.